These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16849538)

  • 41. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
    Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
    Langabeer SE; Grimwade D; Walker H; Rogers JR; Burnett AK; Goldstone AH; Linch DC
    Br J Haematol; 1998 May; 101(2):338-40. PubMed ID: 9609531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
    Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
    Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Long-term Survivor after Congenital Acute Myeloid Leukemia with t(8 ; 16)(p11 ; p13).
    Hanada T; Kanamitsu K; Chayama K; Miyamura T; Kanazawa Y; Muraoka M; Washio K; Imada M; Kageyama M; Takeuchi A; Tamai K; Oda M; Shimada A
    Acta Med Okayama; 2016; 70(1):31-5. PubMed ID: 26899607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia.
    Casas S; Nagy B; Elonen E; Aventín A; Larramendy ML; Sierra J; Ruutu T; Knuutila S
    Leuk Lymphoma; 2003 Nov; 44(11):1935-41. PubMed ID: 14738146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
    von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
    Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
    Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
    Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events.
    Debernardi S; Lillington DM; Chaplin T; Tomlinson S; Amess J; Rohatiner A; Lister TA; Young BD
    Genes Chromosomes Cancer; 2003 Jun; 37(2):149-58. PubMed ID: 12696063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Fluorescence in situ hybridization study of acute myeloid leukemia with cryptic chromosome rearrangements].
    Bai SX; Xue YQ; Chen SN; Pan JL; Wu YF; Shen J; Wang Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):690-3. PubMed ID: 22161107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a
    Panagopoulos I; Andersen K; Ramslien LF; Ikonomou IM; Micci F; Heim S
    Anticancer Res; 2021 Apr; 41(4):1753-1760. PubMed ID: 33813379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
    Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
    Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
    Morikawa J; Li H; Kim S; Nishi K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T
    Int J Oncol; 2003 Sep; 23(3):617-25. PubMed ID: 12888896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative RT-PCR analysis of the MOZ-CBP fusion transcript in therapy-related acute myeloid leukemia with t(8;16)(p11;p13).
    Fujiki A; Imamura T; Furutani A; Hatano W; Asai D; Hirashima Y; Miyachi M; Tamura S; Tsuchiya K; Iehara T; Ishida H; Yoshihara T; Hosoi H
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):402-5. PubMed ID: 22278196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
    Zhuravleva J; Paggetti J; Martin L; Hammann A; Solary E; Bastie JN; Delva L
    Br J Haematol; 2008 Nov; 143(3):378-82. PubMed ID: 18729850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
    Ananthaneni A; Benzar T; Hafiz N; Akabane H
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
    Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
    Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.